Wells Fargo’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.5M Buy
1,086,947
+153,665
+16% +$3.74M 0.01% 1117
2025
Q1
$19.4M Buy
933,282
+586,886
+169% +$12.2M ﹤0.01% 1239
2024
Q4
$8.16M Sell
346,396
-941,829
-73% -$22.2M ﹤0.01% 1803
2024
Q3
$33M Sell
1,288,225
-3,515
-0.3% -$90K 0.01% 913
2024
Q2
$30.3M Sell
1,291,740
-11,559
-0.9% -$271K 0.01% 915
2024
Q1
$37.5M Buy
1,303,299
+527,894
+68% +$15.2M 0.01% 822
2023
Q4
$25.4M Sell
775,405
-498,364
-39% -$16.4M 0.01% 949
2023
Q3
$35.5M Sell
1,273,769
-1,478,845
-54% -$41.2M 0.01% 778
2023
Q2
$93.8M Buy
2,752,614
+277,885
+11% +$9.47M 0.03% 459
2023
Q1
$74.4M Buy
2,474,729
+201,263
+9% +$6.05M 0.02% 526
2022
Q4
$64.2M Buy
2,273,466
+1,185,513
+109% +$33.5M 0.02% 558
2022
Q3
$35.8M Buy
1,087,953
+91,712
+9% +$3.01M 0.01% 752
2022
Q2
$31.4M Sell
996,241
-18,582
-2% -$585K 0.01% 856
2022
Q1
$46.6M Sell
1,014,823
-74,990
-7% -$3.44M 0.01% 798
2021
Q4
$66.7M Buy
1,089,813
+280,528
+35% +$17.2M 0.02% 644
2021
Q3
$60.5M Sell
809,285
-15,756
-2% -$1.18M 0.01% 926
2021
Q2
$76.3M Sell
825,041
-186,668
-18% -$17.3M 0.02% 800
2021
Q1
$89.8M Buy
1,011,709
+396,519
+64% +$35.2M 0.02% 711
2020
Q4
$57.4M Buy
615,190
+177,673
+41% +$16.6M 0.01% 902
2020
Q3
$27.9M Buy
437,517
+61,151
+16% +$3.9M 0.01% 1186
2020
Q2
$19.6M Buy
376,366
+53,259
+16% +$2.78M 0.01% 1382
2020
Q1
$10.1M Buy
323,107
+42,502
+15% +$1.33M ﹤0.01% 1637
2019
Q4
$9.41M Buy
280,605
+272,691
+3,446% +$9.14M ﹤0.01% 1997
2019
Q3
$234K Buy
+7,914
New +$234K ﹤0.01% 4693
2019
Q2
Sell
-2,100
Closed -$69K 5863
2019
Q1
$69K Buy
2,100
+300
+17% +$9.86K ﹤0.01% 5160
2018
Q4
$43K Hold
1,800
﹤0.01% 5268
2018
Q3
$60K Hold
1,800
﹤0.01% 5262
2018
Q2
$52K Buy
+1,800
New +$52K ﹤0.01% 5312
2015
Q3
Sell
-50
Closed -$1K 5862
2015
Q2
$1K Buy
+50
New +$1K ﹤0.01% 5909